Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (151-160 of 327) with videos related to

Pageof 33
Sort By:
Cancer Research|April 1, 1988
Requirement of differentiative signals of both interferon-gamma and 1,25-dihydroxyvitamin D3 for induction and secretion of interleukin-1 by HL-60 cellsG T Spear, D M Paulnock, D O Helgeson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferonsC L Sivinski, D J Lindner, E C Borden, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2006
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor actionJing Li, Daniel J Lindner, Carol Farver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1987
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell culturesJ M Carlin, E C Borden, P M Sondel, et al.
Cancer Research|September 1, 1989
Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitroM M Gottardis, R J Wagner, E C Borden, et al.
Progress in Clinical and Biological Research|January 1, 1985
2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatmentJ A Merritt, D M Meltzer, L A Ball, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosisMamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Journal of the American Pharmacists Association : Japha|April 13, 2020
Syringe services programs and real-world research: An overview for pharmacistsRonald Ron Carico, Nafeeza Hussain, Jordan Sheppard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Effects of diethyldithiocarbamate, an inhibitor of interferon antiviral activity, upon human natural killer cellsB S Edwards, J A Merritt, P A Jelen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1992
The effect of interferon on the metabolism of LDLsG Schectman, S Kaul, R A Mueller, et al.
Pageof 33

Showing results (151-160 of 327) with videos related to

Sort By:
Pageof 33
Cancer Research|April 1, 1988
Requirement of differentiative signals of both interferon-gamma and 1,25-dihydroxyvitamin D3 for induction and secretion of interleukin-1 by HL-60 cellsG T Spear, D M Paulnock, D O Helgeson, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferonsC L Sivinski, D J Lindner, E C Borden, et al.
Cancer Chemotherapy and Pharmacology|November 15, 2006
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor actionJing Li, Daniel J Lindner, Carol Farver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1987
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell culturesJ M Carlin, E C Borden, P M Sondel, et al.
Cancer Research|September 1, 1989
Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitroM M Gottardis, R J Wagner, E C Borden, et al.
Progress in Clinical and Biological Research|January 1, 1985
2-5A synthetase activity in patients with metastatic carcinoma and its response to interferon treatmentJ A Merritt, D M Meltzer, L A Ball, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosisMamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Journal of the American Pharmacists Association : Japha|April 13, 2020
Syringe services programs and real-world research: An overview for pharmacistsRonald Ron Carico, Nafeeza Hussain, Jordan Sheppard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1984
Effects of diethyldithiocarbamate, an inhibitor of interferon antiviral activity, upon human natural killer cellsB S Edwards, J A Merritt, P A Jelen, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|September 1, 1992
The effect of interferon on the metabolism of LDLsG Schectman, S Kaul, R A Mueller, et al.
Pageof 33